| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022969758 |
| P356 | DOI | 10.2165/00023210-200216110-00001 |
| P698 | PubMed publication ID | 12383028 |
| P2093 | author name string | Ross J Baldessarini | |
| P2860 | cites work | Lithium salts in the treatment of psychotic excitement | Q28262417 |
| Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group | Q28375949 | ||
| Effectiveness and safety of long-term antidepressant treatment in bipolar disorder | Q30999313 | ||
| Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder. | Q33587561 | ||
| Placebo control groups in randomized treatment trials: a statistician's perspective | Q33895446 | ||
| Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression | Q33949128 | ||
| Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 | ||
| Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence | Q34023643 | ||
| Methodological issues in developing new acute treatments for patients with bipolar illness. | Q34052847 | ||
| Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders | Q34106678 | ||
| Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications | Q34188583 | ||
| Evolving methodologies in bipolar disorder maintenance research | Q34271249 | ||
| Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium | Q34285233 | ||
| Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis | Q34352552 | ||
| Substance abuse in bipolar disorder | Q34365967 | ||
| Comparative efficacy and tolerability of drug treatments for bipolar disorder | Q34387550 | ||
| Perspectives on the use of anticonvulsants in the treatment of bipolar disorder | Q34503892 | ||
| Is lithium still worth using? An update of selected recent research | Q34565672 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 | ||
| Improvement of phase III psychotropic drug trials by intensive phase II work | Q37234438 | ||
| Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients | Q40736450 | ||
| Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study | Q40909271 | ||
| Lack of insight in psychotic and affective disorders: a review of empirical studies | Q41652659 | ||
| Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients | Q41835417 | ||
| Possible role of antidepressants in precipitating mania and hypomania in recurrent depression | Q42214340 | ||
| Antidepressant-associated mania: a controlled comparison with spontaneous mania | Q42282186 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder | Q42666730 | ||
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
| Demographic and clinical characteristics of individuals in a bipolar disorder case registry | Q45027844 | ||
| Narrowing the gap in treatment of depression | Q46542929 | ||
| Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder. | Q51968630 | ||
| Factors associated with noncompliance with psychiatric outpatient visits. | Q51968895 | ||
| A plea for integrity of the bipolar disorder concept. | Q53493341 | ||
| New Designs for Studies of the Prophylaxis of Bipolar Disorder | Q61480085 | ||
| A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders | Q67483498 | ||
| Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination | Q70504944 | ||
| National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder | Q71589334 | ||
| Course of the Manic-Depressive Cycle and Changes Caused by Treatments | Q72441891 | ||
| Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders | Q73625619 | ||
| Special issues in trial design and use of placebo in bipolar illness | Q73693591 | ||
| Maintenance treatment in bipolar disorder | Q73782425 | ||
| Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders | Q73963098 | ||
| Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials | Q73963103 | ||
| P433 | issue | 11 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 721-729 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Treatment research in bipolar disorder: issues and recommendations | |
| P478 | volume | 16 |
| Q44393866 | Assessment of treatment response in mania: commentary and new findings |
| Q44531492 | CANMAT Guidelines commentary: where does the evidence come from, and how can we use it for our patients? |
| Q38556588 | Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade |
| Q35831460 | Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder |
| Q37100104 | Comparison of mania patients suitable for treatment trials versus clinical treatment |
| Q34575982 | Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD |
| Q35212740 | Diagnostic issues in bipolar disorder |
| Q40217838 | Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease |
| Q36657853 | Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records |
| Q34936432 | Neuronal apoptosis and motor deficits in mice with genetic inhibition of GSK-3 are Fas-dependent |
| Q51900833 | Nutrition and exercise behavior among patients with bipolar disorder. |
| Q35945257 | Olanzapine: a review of its use in the management of bipolar I disorder |
| Q34098311 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. |
| Q38004093 | Quetiapine: a review of its use in the management of bipolar depression |
| Q35154713 | Rapid-cycling bipolar disorder: effects of long-term treatments |
| Q41948705 | Receptor crosstalk: haloperidol treatment enhances A(2A) adenosine receptor functioning in a transfected cell model |
| Q35940851 | Safety considerations in pharmacotherapy of bipolar disorder |
| Q35099750 | Teaching ethics of psychopharmacology research in psychiatric residency training programs |
| Q54643814 | Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. |
| Q28602260 | Using Smartphones to Monitor Bipolar Disorder Symptoms: A Pilot Study |
Search more.